OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,600 | +17.1% | 2,500,000 | 0.0% | 0.41% | +62.2% |
Q2 2023 | $8,200 | +27.1% | 2,500,000 | 0.0% | 0.25% | -33.7% |
Q1 2023 | $6,450 | +38.7% | 2,500,000 | 0.0% | 0.38% | +47.3% |
Q4 2022 | $4,650 | -99.9% | 2,500,000 | 0.0% | 0.26% | +32.7% |
Q3 2022 | $4,600,000 | -14.4% | 2,500,000 | 0.0% | 0.20% | -31.7% |
Q2 2022 | $5,375,000 | -31.5% | 2,500,000 | 0.0% | 0.29% | -12.8% |
Q1 2022 | $7,850,000 | -2.2% | 2,500,000 | 0.0% | 0.33% | +50.9% |
Q4 2021 | $8,025,000 | -4.5% | 2,500,000 | 0.0% | 0.22% | +16.0% |
Q3 2021 | $8,400,000 | -14.1% | 2,500,000 | 0.0% | 0.19% | -5.1% |
Q2 2021 | $9,775,000 | -2.7% | 2,500,000 | 0.0% | 0.20% | +11.2% |
Q1 2021 | $10,050,000 | +74.0% | 2,500,000 | 0.0% | 0.18% | +43.5% |
Q4 2020 | $5,775,000 | -59.8% | 2,500,000 | 0.0% | 0.12% | -64.4% |
Q3 2020 | $14,350,000 | – | 2,500,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |